Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration
ABSTRACT: Background: Low-dose aspirin can cause gastric and duodenal ulceration, hereafter called peptic ulcer disease (PUD). Predisposition is thought to be related to clinical and genetic factors; our aim was to identify genetic risk factors associated with aspirin-induced PUD. Methods: Patients...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e356fc46996447cfa33cfd26c73f0564 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e356fc46996447cfa33cfd26c73f0564 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e356fc46996447cfa33cfd26c73f05642021-12-04T04:34:42ZGenome-Wide association between EYA1 and Aspirin-induced peptic ulceration2352-396410.1016/j.ebiom.2021.103728https://doaj.org/article/e356fc46996447cfa33cfd26c73f05642021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2352396421005223https://doaj.org/toc/2352-3964ABSTRACT: Background: Low-dose aspirin can cause gastric and duodenal ulceration, hereafter called peptic ulcer disease (PUD). Predisposition is thought to be related to clinical and genetic factors; our aim was to identify genetic risk factors associated with aspirin-induced PUD. Methods: Patients (n=1478) were recruited from 15 UK hospitals. Cases (n=505) were defined as patients with endoscopically confirmed PUD within 2 weeks of using aspirin and non-aspirin Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). They were compared to two control groups: patients with endoscopically confirmed PUD without any history of NSAID use within 3 months of diagnosis (n=495), and patients with no PUD on endoscopy (n=478). A genome-wide association study (GWAS) of aspirin-induced cases (n=247) was compared to 476 controls. The results were validated by replication in another 84 cases and 162 controls. Findings: The GWAS identified one variant, rs12678747 (p=1·65×10−7) located in the last intron of EYA1 on chromosome 8. The association was replicated in another sample of 84 PUD patients receiving aspirin (p=0·002). Meta-analysis of discovery and replication cohort data for rs12678747, yielded a genome-wide significant association (p=3·12×10−11; OR=2·03; 95% CI 1·65-2·50). Expression of EYA1 was lower at the gastric ulcer edge when compared with the antrum. Interpretation: Genetic variation in an intron of the EYA1 gene increases the risk of endoscopically confirmed aspirin-induced PUD. Reduced EYA1 expression in the upper gastrointestinal epithelium may modulate risk, but the functional basis of this association will need mechanistic evaluation. Funding: Department of Health Chair in Pharmacogenetics, MRC Centre for Drug Safety Science and the Barts Cardiovascular NIHR Biomedical Research Centre, British Heart Foundation (BHF)Stephane BourgeoisDaniel F. CarrCrispin O. MusumbaAlexander PenroseCelestine EsumeAndrew P. MorrisAndrea L. JorgensenJ. Eunice ZhangD. Mark PritchardPanos DeloukasMunir PirmohamedElsevierarticleNSAIDulcerAspirinGWASMedicineRMedicine (General)R5-920ENEBioMedicine, Vol 74, Iss , Pp 103728- (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
NSAID ulcer Aspirin GWAS Medicine R Medicine (General) R5-920 |
spellingShingle |
NSAID ulcer Aspirin GWAS Medicine R Medicine (General) R5-920 Stephane Bourgeois Daniel F. Carr Crispin O. Musumba Alexander Penrose Celestine Esume Andrew P. Morris Andrea L. Jorgensen J. Eunice Zhang D. Mark Pritchard Panos Deloukas Munir Pirmohamed Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration |
description |
ABSTRACT: Background: Low-dose aspirin can cause gastric and duodenal ulceration, hereafter called peptic ulcer disease (PUD). Predisposition is thought to be related to clinical and genetic factors; our aim was to identify genetic risk factors associated with aspirin-induced PUD. Methods: Patients (n=1478) were recruited from 15 UK hospitals. Cases (n=505) were defined as patients with endoscopically confirmed PUD within 2 weeks of using aspirin and non-aspirin Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). They were compared to two control groups: patients with endoscopically confirmed PUD without any history of NSAID use within 3 months of diagnosis (n=495), and patients with no PUD on endoscopy (n=478). A genome-wide association study (GWAS) of aspirin-induced cases (n=247) was compared to 476 controls. The results were validated by replication in another 84 cases and 162 controls. Findings: The GWAS identified one variant, rs12678747 (p=1·65×10−7) located in the last intron of EYA1 on chromosome 8. The association was replicated in another sample of 84 PUD patients receiving aspirin (p=0·002). Meta-analysis of discovery and replication cohort data for rs12678747, yielded a genome-wide significant association (p=3·12×10−11; OR=2·03; 95% CI 1·65-2·50). Expression of EYA1 was lower at the gastric ulcer edge when compared with the antrum. Interpretation: Genetic variation in an intron of the EYA1 gene increases the risk of endoscopically confirmed aspirin-induced PUD. Reduced EYA1 expression in the upper gastrointestinal epithelium may modulate risk, but the functional basis of this association will need mechanistic evaluation. Funding: Department of Health Chair in Pharmacogenetics, MRC Centre for Drug Safety Science and the Barts Cardiovascular NIHR Biomedical Research Centre, British Heart Foundation (BHF) |
format |
article |
author |
Stephane Bourgeois Daniel F. Carr Crispin O. Musumba Alexander Penrose Celestine Esume Andrew P. Morris Andrea L. Jorgensen J. Eunice Zhang D. Mark Pritchard Panos Deloukas Munir Pirmohamed |
author_facet |
Stephane Bourgeois Daniel F. Carr Crispin O. Musumba Alexander Penrose Celestine Esume Andrew P. Morris Andrea L. Jorgensen J. Eunice Zhang D. Mark Pritchard Panos Deloukas Munir Pirmohamed |
author_sort |
Stephane Bourgeois |
title |
Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration |
title_short |
Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration |
title_full |
Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration |
title_fullStr |
Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration |
title_full_unstemmed |
Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration |
title_sort |
genome-wide association between eya1 and aspirin-induced peptic ulceration |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/e356fc46996447cfa33cfd26c73f0564 |
work_keys_str_mv |
AT stephanebourgeois genomewideassociationbetweeneya1andaspirininducedpepticulceration AT danielfcarr genomewideassociationbetweeneya1andaspirininducedpepticulceration AT crispinomusumba genomewideassociationbetweeneya1andaspirininducedpepticulceration AT alexanderpenrose genomewideassociationbetweeneya1andaspirininducedpepticulceration AT celestineesume genomewideassociationbetweeneya1andaspirininducedpepticulceration AT andrewpmorris genomewideassociationbetweeneya1andaspirininducedpepticulceration AT andrealjorgensen genomewideassociationbetweeneya1andaspirininducedpepticulceration AT jeunicezhang genomewideassociationbetweeneya1andaspirininducedpepticulceration AT dmarkpritchard genomewideassociationbetweeneya1andaspirininducedpepticulceration AT panosdeloukas genomewideassociationbetweeneya1andaspirininducedpepticulceration AT munirpirmohamed genomewideassociationbetweeneya1andaspirininducedpepticulceration |
_version_ |
1718373001379971072 |